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Abstract
Copy number variations (CNVs) are one of the main sources of variability in the human genome. Many CNVs are associated
with various diseases including cardiovascular disease. In addition to hybridization-based methods, next-generation
sequencing (NGS) technologies are increasingly used for CNV discovery. However, respective computational methods
applicable to NGS data are still limited. We developed a novel CNV calling method based on outlier detection applicable to
small cohorts, which is of particular interest for the discovery of individual CNVs within families, de novo CNVs in trios and/or
small cohorts of specific phenotypes like rare diseases. Approximately 7,000 rare diseases are currently known, which
collectively affect ,6% of the population. For our method, we applied the Dixon’s Q test to detect outliers and used a
Hidden Markov Model for their assessment. The method can be used for data obtained by exome and targeted
resequencing. We evaluated our outlier- based method in comparison to the CNV calling tool CoNIFER using eight HapMap
exome samples and subsequently applied both methods to targeted resequencing data of patients with Tetralogy of Fallot
(TOF), the most common cyanotic congenital heart disease. In both the HapMap samples and the TOF cases, our method is
superior to CoNIFER, such that it identifies more true positive CNVs. Called CNVs in TOF cases were validated by qPCR and
HapMap CNVs were confirmed with available array-CGH data. In the TOF patients, we found four copy number gains
affecting three genes, of which two are important regulators of heart development (NOTCH1, ISL1) and one is located in a
region associated with cardiac malformations (PRODH at 22q11). In summary, we present a novel CNV calling method based
on outlier detection, which will be of particular interest for the analysis of de novo or individual CNVs in trios or cohorts up
to 30 individuals, respectively.
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Introduction
Many genomic studies have revealed a high variability of the
human genome, ranging from single nucleotide variations and
short insertions or deletions to larger structural variations and
aneuploidies. Structural variations include copy number variations
(CNVs), which cause gains (duplications) or losses (deletions) of
genomic sequence. These copy number changes are usually
defined to be longer than ,500 bases, including large variations
with more than 50 kilobases [1,2]. Recent studies have identified
CNVs associated with a number of complex diseases such as
Crohn’s disease, intellectual disability and congenital heart disease
[3–6].
Congenital heart disease (CHD) are the most common birth
defect in human with an incidence of around 1% in all live births
[7,8]. They comprise a heterogeneous group of cardiac malfor-
mations that arise during heart development. The most common
cyanotic form of CHD is Tetralogy of Fallot (TOF), which
accounts for up to 10% of all heart malformations [9]. TOF is
characterized by a ventricular septal defect with an overriding
aorta, a right ventricular outflow tract obstruction and a right
ventricular hypertrophy [10]. It is a well-recognized subfeature of
syndromic disorders such as DiGeorge syndrome (22q11 deletion),
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Down syndrome, Holt-Oram syndrome and Williams-Beuren
syndrome [11]. Deletions at the 22q11 locus account for up to
16% of TOF cases [12] and copy number changes at other loci
were identified in several syndromic TOF patients [13–15].
However, the majority of TOFs are isolated, non-syndromic cases
caused by a multifactorial inheritance with genetic-environmental
interactions, which is also the situation for the majority of CHDs
[16]. Using SNP arrays, three recent studies also identified CNVs
in large cohorts of non-syndromic TOF patients [17–19].
Observing the overlap between these studies with hundreds of
cases revealed only one locus (1q21.1) affected in 11 patients
(Figure 1), which underlines the heterogeneous genetic back-
ground of non-syndromic TOF.
As an alternative to the conventional SNP arrays, next-
generation sequencing (NGS) technologies have been widely used
to detect single or short sequence variations. The obtained
sequence data can also be used to find larger CNVs. Depending
on the sequencing technologies, there are different computational
approaches for detecting copy numbers from NGS data. For
exome sequencing or targeted resequencing, the read-depth or
depth of coverage approach is widely used. It assumes that the
mapped reads are randomly distributed across the reference
genome or targeted regions. Based on this assumption, the read-
depth approach analyses differences from the expected read
distribution to detect duplications (higher read depth) and
deletions (lower read depth) [20]. Applying this approach, several
tools have been developed to identify CNVs from exome
sequencing data, such as FishingCNV, CONTRA, ExomeCNV,
ExomeDepth, XHMM, CoNVEX and CoNIFER [21–27].
Here, we aimed to identify copy number alterations in a small
cohort of non-syndromic TOF patients based on targeted
resequencing data. Assuming a heterogeneous genetic background
with individual disease-relevant CNVs, we developed a novel
CNV calling method based on outlier detection using Dixon’s Q
test and assessment of outliers using a Hidden Markov Model
(HMM). For evaluation, we applied our method to a small cohort
of HapMap samples and compared it to results obtained with
ExomeDepth and CoNIFER. Subsequently, our method and
CoNIFER were used to detect CNVs in the TOF patients. Two
copy number gains were identified by both methods and are
duplications in the PRODH gene located at the 22q11 locus. In
addition, our outlier-based method found a gain in NOTCH1 as
well as in ISL1. All four CNVs could be validated by quantitative
real-time PCR.
Materials and Methods
Ethics Statement
Studies on TOF patients were performed according to
institutional guidelines of the German Heart Institute in Berlin,
with approval of the ethics committee of the Charite´ Medical
Faculty and informed written consent of patients and/or parents,
kin, caretakers, or guardians on the behalf of the minors/children
participants involved in our study.
TOF Samples and DNA Targeted Resequencing
Targeted resequencing was performed for eight TOF patients,
which are unrelated sporadic cases with a well-defined coherent
Figure 1. Overlap of three recent CNV studies in TOF patients. All three studies are based on SNP arrays. Loci with detected CNVs are
depicted according to their respective cytoband. For 1q21.1, which was identified in all three studies, the RefSeq genes that are affected in at least
one patient in each of the publications are listed in the order of their genomic position. Genes that are expressed in mouse heart development (E8.5–
E12.0, Mouse Atlas of Gene Expression at http://www.mouseatlas.org/mouseatlas_index_html) are marked in bold. # denotes the number of
individuals.
doi:10.1371/journal.pone.0085375.g001
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phenotype and no further anomalies. Blood samples (TOF-23,
TOF-24, TOF-25, TOF-26, TOF-27) and cardiac tissue from the
right ventricle (TOF-01, TOF-02, TOF-18) were collected in
collaboration with the German Heart Institute in Berlin and the
National Registry of Congenital Heart Disease in Berlin and used
for the extraction of genomic DNA. 3–5 mg of genomic DNA were
used for Roche NimbleGen sequence capturing using 365 K
arrays. For array design, 867 genes and 167 microRNAs (12,910
exonic targets representing 4,616,651 target bases) were selected
based on knowledge gained in various projects [28–30]. DNA
enriched after NimbleGen sequence capturing was sequenced
using the Illumina Genome Analyzer (GA) IIx (36 bp paired-end
reads). Sequencing was performed by Atlas Biolabs (Berlin)
according to manufacturers’ protocols.
On average, sequencing resulted in 13,331,661 read pairs per
sample (Table 1). Average read depths of 756 and base quality
scores of 34 (Phred scores) were reached in the captured regions
over all samples (Table 1 and Figure 2).
HapMap Samples
We used exome sequencing data from eight HapMap individ-
uals (NA18507, NA18555, NA18956, NA19240, NA12878,
NA15510, NA18517, NA19129). The exomes were captured
using Roche NimbleGen EZ Exome SeqCap Version 1 and
sequencing was performed using an Illumina HiSeq 2000 platform
with 50 bp paired-end reads. The exome sequence data are
available from the Short Read Archive at the NCBI (SRA039053).
The reads were further trimmed to 36 bp.
Outlier-based CNV Calling Method
Our CNV calling method was developed for exome or targeted
resequencing data of small sets of samples (at least 3 and at most
30) assuming that the bias in the captured regions is similar in all
samples enriched and sequenced with the same technology. Based
on a heterogeneous genetic background in the cohort, it was
further assumed that a unique disease-related copy number
change is only present in very few samples.
First, read mapping and calculation of copy number values were
performed for each sample separately. The sequenced reads were
mapped to the targeted regions of the reference genome using
BWA v.0.5.9 in paired-end mode (‘sampe’) with default param-
eters [31]. Up- and downstream, the targeted regions (usually
exons) were extended by 35 bp (read length minus one base pair)
to correctly capture the coverage at the start and end of a region.
After mapping, the extended regions with their mapped reads
were joined chromosome-wise and the tool mRCaNaVaR v0.34
[32] was used to split the joined regions into non-overlapping
windows of 100 bp in length. The copy number value C for each
window WM{1,…,n} of a sample SM{1,…,n} was then calculated
by mRCaNaVaR using the following formula:
CSW~
Number of reads mapped to W
Average number of reads mapped over all windows
|2,
with additional GC correction [32] (Figure 3A). Reads spanning
the border of two windows were assigned to the left window. In
general, our method calculates a copy number value using
Table 1. Number and quality of 36 bp paired-end reads obtained from targeted resequencing in TOF patients using Illumina’s
Genome Analyzer IIx platform.
Captured regions
Sample
Number of
reads
Number of read
pairs
Phred quality
score
Median
coverage
Mean
coverage
Target bases with $10x
coverage
TOF-01 31,942,782 15,971,391 33.3 40 47 93.85%
TOF-02 26,970,680 13,485,340 32.7 66 76 97.70%
TOF-18 25,476,308 12,738,154 35.4 71 80 98.35%
TOF-23 20,885,192 10,442,596 35.0 60 69 97.41%
TOF-24 25,483,166 12,741,583 34.7 51 58 96.72%
TOF-25 30,551,674 15,275,837 34.6 84 92 98.91%
TOF-26 27,878,750 13,939,375 34.7 75 84 98.34%
TOF-27 24,118,022 12,059,011 34.6 78 90 98.00%
doi:10.1371/journal.pone.0085375.t001
Figure 2. Base qualities versus coverage values. Scatterplot
indicates the average base qualities (Phred scores) and depths of
coverage for samples targeted resequenced by Illumina’s Genome
Analyzer IIx platform (36 bp paired-end reads).
doi:10.1371/journal.pone.0085375.g002
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mrCaNaVaR, which can accurately predict CNVs with at least 4x
coverage [32].
Second, Dixon’s Q test was applied for each window at the
same position over all samples to identify gains or losses considered
Figure 3. Outlier-based CNV calling method. (A) Read mapping and calculation of copy number value per window. Reads are mapped to
extended targeted regions, which are then joined chromosome-wise. mrCaNaVaR is used to split the joined regions into windows. For each window,
its copy number value is calculated by mrCaNaVaR, where CSW represents the value for window W in sample S. (B) Dixon’s Q test is applied for each
window over all samples to identify outliers. Here, sample 1 represents an outlier (loss, L) for the first, second, third and fifth window, while sample 2
represents an outlier (gain, G) for the fourth window. (C) Assessment of outliers using a Hidden Markov Model (HMM). In the given example, the
fourth window of sample 1 is considered as normal (N). After applying the HMM, it will also be considered as a loss. Similarly, the fourth window of
sample 2 is considered as normal after applying the HMM. A region is called as a copy number alteration, if at least five continuous windows show the
same kind of change, i.e. either gain or loss.
doi:10.1371/journal.pone.0085375.g003
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as outliers (Figure 3B). This test was introduced in 1950 for the
analysis of extreme values and for the rejection of outlying values
[33]. We used the formulas for r10 and r20 [34], also known as
type10 and type20 in the R package ‘outliers’ v0.14 (http://www.
R-project.org). Type10 (recommended for 3–7 samples) can only
detect a single outlying window at the same genomic position over
all samples, while type20 (recommended for 8–30 samples) can
identify exactly two outlying windows, meaning the Q test will not
detect outliers if more than 2 outliers are present. For each
window, we first applied type20, however, if no two significant
outliers (samples) were found, type10 was used to detect at most
one outlier. Note that our method can also be applied using type10
and type20 independently. Outliers were regarded as significant
with a p-value of less than or equal to 0.01. In general, the higher
the p-value cutoff, the higher the number of detected outliers but
also the number of false positives, i.e. the p-value is a tuning
parameter for sensitivity of our method.
In the third and final step, the samples were again considered
separately. For each sample, a Hidden Markov Model [35] was
applied to get the most likely state of each window (i.e. gain, loss or
normal). The initial transition and emission probabilities of the
HMM are given in Table S1 and the values were recomputed
using the Baum-Welch algorithm [36] implemented in the R
package ‘HMM’ v1.0. The most likely sequence of the hidden
states was then found by the Viterbi algorithm [37] also
implemented in the R package ‘HMM’. Finally, a region was
called as copy number gain or loss if at least five continuous
windows were considered as a gain or loss, respectively (Figure 3C).
This results in a minimum size of 500 bp for detectable CNVs.
We have included a script, written in R 2.15.1 (http://www.R-
project.org), for our CNV calling method based on outlier
detection in exome and/or targeted resequencing data (Script S1).
CNV Validation
Genomic DNA was extracted from whole blood or cardiac
biopsies using standard procedures. Quantitative real-time PCR
was carried out using GoTag qPCR Master Mix (Promega) on an
ABI PRISM 7900HT Sequence Detection System (Applied
Biosystems) according to the manufacturer’s instructions and with
normalization to the RPPH1 gene. Primer sequences are available
on request. As a reference, genomic DNA from the HapMap
individual NA10851 was obtained from the Coriell Cell Repos-
itories (New Jersey, USA).
Results and Discussion
We applied our outlier-based CNV calling method to eight
HapMap control samples and intersected our exome-based calls
from five of the samples with previously generated calls from high-
resolution microarray-based comparative genomic hybridization
(array-CGH) [2]. In addition to our method, we used the two
publicly available tools ExomeDepth and CoNIFER [23,27].
Other tools such as CONTRA, FishingCNV, CoNVEX and
ExomeCNV could not be applied to this dataset since they need
either matched or non-matched controls.
CoNIFER (copy number inference from exome reads) is a
method that combines the read-depth approach with singular
value decomposition (SVD) normalization to identify rare and
common copy number alterations from exome sequencing data
[27]. Applying our method with type10 Dixon’s Q test (assuming
at most one outlier), we found 40 CNVs over the five HapMap
controls (Table S2), out of which 37 regions were also identified in
the array-CGH data, showing a high positive predictive value of
93%. With type20 (assuming at most two outliers), we found 65
copy number changes (Table S3), out of which 55 regions are
present in the array-CGH data, resulting in a positive predictive
value of 85%. Using CoNIFER, 32 CNVs were identified in the
Table 2. Exome sequencing-based CNV calls in HapMap samples.
Method
Number
of CNVs Validation dataset
Number of
overlapping CNVs
Positive predictive
value Sensitivity
Outlier-based calling method with type10 40 3,330 arrayCGH calls 37 93% 1.1%
Outlier-based calling method with
type20 including type10
65 55 85% 1.7%
CoNIFER 32 26 81% 0.8%
ExomeDepth 1,555 253 16% 7.6%
doi:10.1371/journal.pone.0085375.t002
Table 3. Targeted resequencing-based CNV calls in TOF patients.
Method
Type of
variation Position (hg19) Length in bp Gene Sample
Outlier-based calling method with
type20 including type10
Gain chr5:50,689,340–50,689,940 601 ISL1 TOF-23
Gain chr9:139,402,477–139,404,228 1,752 NOTCH1 TOF-01
Gain chr22:18,900,412–18,901,127 716 PRODH TOF-02
Gain chr22:18,910,691–18,918,575 7,885 PRODH TOF-02
CoNIFER Gain chr22:18,900,414–18,905,939 5,526 PRODH TOF-02
Gain chr22:18,910,575–18,923,866 13,292 PRODH TOF-02
doi:10.1371/journal.pone.0085375.t003
Outlier-Based CNV Calling Method
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five HapMap exome controls and only 26 of these regions are also
present in the array-CGH data [27], which corresponds to a
positive predictive value of 81% (Table 2). Comparing our results
to those obtained from CoNIFER, we found that with type10 16
out of 40 regions (40%) are overlapping with regions called by
CoNIFER by at least one base pair. Vice versa, 11 out of 32
regions (34%) overlap with our calls. With type20, 24 out of our 65
called regions (37%) overlap with those from CoNIFER and
oppositely, 47% of the regions (15 out of 32) overlap with our calls.
In general, CNV regions identified by CoNIFER are longer than
those found by our method, meaning that regions called by
CoNIFER can correspond to more than one of our CNVs, which
explains the different overlap proportions.
Overall, our method was able to detect more copy number
changes and has a higher proportion of true positives compared to
CoNIFER. However, there is still a large number of CNVs
observed in the array-CGH data, which were identified by neither
of the two exome-based methods (Table 2). This can for example
be explained by their location in segmental duplications and
polymorphic but not duplicated regions [27].
ExomeDepth uses a beta-binomial model for the read count
data to identify CNVs from exome sequencing data [24]. We
applied ExomeDepth with default parameters to the eight
HapMap samples and intersected the found CNVs from five of
the samples with previously generated calls from array-CGH. In
summary, ExomeDepth found 1,555 CNVs in the five samples
(median number of 286 CNVs per sample). Out of these, only 253
CNVs overlapped with 3,330 array-CGH calls, which suggest a
positive predictive value of 16% and sensitivity of 7.6% (Table 2).
Interestingly, all the five rare CNVs in the five HapMap samples
(see Krumm et al. 2012, Table S2 [27]) were found by our method,
CoNIFER and ExomeDepth. Moreover, ExomeDepth identified
more CNVs as compared to CoNIFER and to our method
(Table 2), however; the positive predictive value is very low.
Therefore, we decided not to use ExomeDepth for detecting
CNVs in the TOF patients.
To identify copy number alterations in TOF patients, we
applied our outlier-based method as well as CoNIFER to targeted
resequencing data of our eight cases. Using our method, we found
four copy number gains in three genes, namely ISL1, NOTCH1
and PRODH. CoNIFER only identified two gains in PRODH,
which overlap with the two regions found by our method (Table 3
and Figure 4A). We further validated all four regions identified by
our method using quantitative real-time PCR (Figure 4B–D). ISL1
is a homeobox transcription factor that marks cardiovascular
progenitors [38] and is known to be associated with human
congenital heart disease [39]. NOTCH1 is a transmembrane
receptor involved in the NOTCH signaling pathway, which plays
a crucial role in heart development [40]. Mutations in NOTCH1
are associated with a spectrum of congenital aortic valve anomalies
Figure 4. CNVs in TOF patients. (A) CNVs detected in PRODH by CoNIFER and our outlier-based CNV calling method. The duplications are
depicted in the UCSC Genome Browser as blue bars. The positions of the two quantitative real-time PCR products selected for validation are shown as
light and dark grey bars, respectively. (B) Quantitative real-time PCR validation of PRODH copy number gains. Measurement was performed at two
different positions (light and dark grey bars, respectively) and normalized to the RPPH1 gene. The HapMap individual NA10851 was used as a
reference. The plot shows a representative of two independent measurements, which were each performed in triplicates. (C–D) Validation of copy
number gains in ISL1 and NOTCH1, respectively, that were only identified by our outlier-based CNV calling method.
doi:10.1371/journal.pone.0085375.g004
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[41,42] and a copy number loss was identified in a patient with
TOF [17] (locus 9q34.3, Figure 1). The mitochondrial protein
PRODH catalyzes the first step in proline degradation and is
located in the 22q11.2 locus. Deletions in this region are associated
with the DiGeorge syndrome and 80% of cases harbor cardio-
vascular anomalies [43]. A copy number gain and two losses in the
22q11.2 locus overlapping PRODH were also identified in sporadic
TOF patients [17,18] (Figure 1).
In summary, we developed an outlier-based CNV calling
method for a small cohort size of up to 30 individuals. The
exploration of the human phenotype and its genetic and molecular
background is the challenge of the next century and it is already
clear that more precise phenotyping will lead to smaller cohort
sizes. Here, novel approaches will be of exceptional relevance.
Moreover, analyzing small patient cohorts is of special interest for
rare diseases with only few available patient samples. Approxi-
mately 7,000 rare diseases are currently known and together affect
about 6% of the population [44]. Our method is based on the
assumption that individual CNVs (outliers) are disease-relevant
and can be applied to exome as well as targeted resequencing data.
Both sequencing techniques achieve a high read coverage over the
targeted regions. Nevertheless, there are non-uniform patterns in
the read depth resulting mainly from repetitive regions. Thus, the
detection of copy number alterations is limited in these genomic
regions, which is shown by the high number of false negatives
compared to array-CGH [27].
We evaluated our method using publicly available data of eight
HapMap samples and subsequently applied it to a small number of
TOF patients. Compared to CoNIFER we identified more CNVs
in both the HapMap samples as well as in our TOF cohort. In
general, our method assumes a uniform read distribution over all
exons of all individuals enriched and sequenced with the same
technology to compare read counts between all samples to detect
outliers. In contrast, CoNIFER considers the read depth across all
individuals after SVD normalization. This difference is also
reflected by the overlap of their calls in the eight HapMap
samples. Although the general overlap is relatively low, we were
able to identify all rare CNVs detected by CoNIFER. In addition
to searching for rare CNVs, we also found a subset of common
CNVs called by CoNIFER. This might be explained by variations
present in only one or two of the eight individuals, but defined as
common based on their frequency in a larger population.
In our TOF cohort comprising eight cases, we found four copy
number gains in three patients, while CoNIFER only detected two
of the gains in one patient. All four gains could be validated and in
addition, the three genes affected by the CNVs are important
regulators of heart development (NOTCH1, ISL1) or are located in
a region associated with cardiac malformations (PRODH). Two of
the variations also overlap with copy number alterations in TOF
patients previously identified by array-CGH [17,18]. Taken
together, this illustrates the advantage of using an outlier-based
detecting method in a small cohort with a heterogeneous genetic
background. Thus, our method is of special interest for small
cohorts of specific phenotypes like rare diseases. Moreover, it can
be used for the discovery of individual CNVs within families and de
novo CNVs in trios.
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